Abstract
The kinetics of decomposition of phosphomonoesters of hydroxy-methyl-5,5-diphenylhydantoin (1), estrone (2), 17β-testosterone (3), 1-phenylvinyl alcohol (4), and 17α-testosterone (5) were studied in rat whole blood at 25 and/or 37°C. As the acidity of the leaving hydroxyl group of the phosphomonoester increased, there was a tendency for the rate of hydrolysis to increase, except for the anomalous behavior of 4, which was consistent with its relative rate of hydrolysis in aqueous solutions (1). In addition, the kinetics of hydrolysis of 1–5 and p-nitrophenyl phosphate (p-NPP) were studied in the presence of isolated alkaline phosphatases from a variety of sources. The initial rate of production of 17α- and 17β-testosterone from their respective phosphate esters (5 and 3), in the presence of human placental alkaline phosphatase, revealed that 3 was hydrolyzed 5.3-fold more rapidly than 5. This difference in reactivity might have been the result of differences in the stereochemical and/or steric nature of the two isomers. For p-NPP, 1, 2, and 4, the k cat and k cat / K m values determined in the presence of the various alkaline phosphatases showed little variation, whereas for 3, the catalytic constants, k cat and k cat / K m, were found to be dramatically less than those found for p-NPP, 1, 2, and 4. This suggested that the reaction steps, involving the noncovalent binding of the phosphomonoester to the enzyme and/or the nucleophilic displacement of the leaving alcohol of the phosphomonoester by the reactive amino acid residue of the enzyme, might have been less favorable in the case of 3, where the carbon atom of the ester linkage was secondary and was associated with a rigid ring system.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
A. S. Kearney and V. J. Stella. The anomalous hydrolytic behavior of 1-phenylvinyl phosphate. Pharm. Res. (in press).
J. C. Melby and M. St. Cyr. Comparative studies on absorption and metabolic disposal of water-soluble corticosteroid esters. Metabolism 10:75–82 (1961).
L. E. Hare, K. C. Yeh, C. A. Ditzler, F. G. McMahon, and D. E. Duggan. Bioavailability of dexamethasone II. Dexamethasone phosphate. Clin. Pharmacol. Ther. 18:330–337 (1975).
S. Miyabo, T. Nakamura, S. Kuwazima, and S. Kishida. A comparison of the bioavailability of dexamethasone phosphate and sulfate in man. Eur. J. Clin. Pharmacol. 20:277–282 (1981).
P. Rohdewald, H. Mollmann, J. Barth, J. Rehder, and H. Derendorf. Pharmacokinetics of dexamethasone and its phosphate ester. Biopharm. Drug. Dis. 8:205–212 (1987).
P. O. Gunnarsson, S. B. Andersson, S. A. Johansson, T. Nilsson, and G. Plym-Forshell. Pharmacokinetics of estramustine phosphate. Eur. J. Clin. Pharmacol. 26:113–119 (1984).
H. Mollmann, P. Rohdewald, J. Barth, C. Mollmann, M. Verho, and H. Derendorf. Comparative pharmacokinetics of methylprednisolone phosphate and hemisuccinate in high doses. Pharm. Res. 5:509–513 (1988).
H. Mollmann, P. Rohdewald, J. Barth, M. Verho, and H. Derendorf. Pharmacokinetics and dose linearity testing of methylprednisolone phosphate. Biopharm. Drug. Disp. 10:453–464 (1989).
R. M. DeHaan, C. M. Metzler, D. Schellenberg, and W. D. Vandenbosch. Pharmacokinetic studies of clindamycin phosphate. J. Clin. Pharmacol. 13:190–209 (1973).
K. I. Plaisance, G. L. Drusano, A. Forrest, R. J. Townsend, and H. C. Standiford. Pharmacokinetic evaluation of two dosage regimens of clindamycin phosphate. Antimicrob. Agents Chemother. 33:618–620 (1989).
G. A. LePage, S. R. Naik, S. B. Katakkar, and A. Khaliq. 9-β-D-Arabinofuranosyladenine-5′-phosphate metabolism and excretion in humans. Cancer Res. 35:3036–3040 (1975).
H. Mollmann, P. Rohdewald, E. W. Schmidt, V. Salomon, and H. Derendorf. Pharmacokinetics of triamcinolone acetonide and its phosphate ester. Eur. J. Clin. Pharmacol. 29:85–89 (1985).
B. A. Boucher, A. M. Bombassaro, S. N. Rasmussen, C. B. Watridge, R. Achari, and P. Turlapaty. Phenytoin prodrug 3-phosphoryloxymethyl phenytoin (ACC-9653): Pharmacokinetics in patients following intravenous and intramuscular administration. J. Pharm. Sci. 78:929–932 (1989).
N. Gerber, D. C. Mays, K. H. Donn, A. Laddu, R. M. Guthrie, P. Turlapaty, C. Y. Quon, and W. K. Rivenburg. Safety, tolerance and pharmacokinetics of intravenous doses of the phosphate ester of 3-hydroxymethyl-5,5-diphenylhydantoin: A new prodrug of phenytoin. J. Clin. Pharmacol. 28:1023–1032 (1988).
S. A. Varia, S. Schuller, K. B. Sloan, and V. J. Stella. Phenytoin prodrugs III. Water-soluble prodrugs for oral and/or parenteral use. J. Pharm. Sci. 73:1068–1073 (1984).
O. A. Bessey, O. H. Lowry, and M. J. Brock. A method for the rapid determination of alkaline phosphatase with five cubic millimeters of serum. J. Biol. Chem. 164:321–329 (1946).
M. Martland, F. S. Hansman, and R. Robison. The phosphoricesterase of blood. Biochem. J. 18:1152–1160 (1924).
M. A. M. Abul-Fadl and E. J. King. Properties of the acid phosphatases of erythrocytes and of human prostate gland. Biochem. J. 45:51–60 (1949).
D. A. Hopkinson, N. Spencer, and H. Harris. Red cell acid phosphatase varients: A new human polymorphism. Nature 199:969–971 (1963).
P. Haspra, A. Sutter, and J. Wirz. Acidity of acetophenone enol in aqueous solution. Angew. Chem. Int. Ed. Engl. 18:617–619 (1979).
V. V. Egorova, A. V. Zakharychev, and S. N. Ananchenko. Structure and reactivity of steroids VI. Long range effects in a series of Δl,3,5(10)-estratriene compounds. Tetrahedron 29:301–307 (1973).
S. A. Varia, S. Schuller, and V. J. Stella. Phenytoin prodrugs IV: Hydrolysis of various 3-(hydroxymethyl)phenytoin esters. J. Pharm. Sci. 73:1074–1080 (1984).
J. March. Advanced Organic Chemistry, 3rd ed., Wiley, New York, 1985, p. 221.
R. Sokal and F. J. Rohlf. Biometry, 2nd ed., W. H. Freeman, New York, 1981, pp. 499–506.
K. H. Byington. Dopamine 3 or 4 phosphate: Pharmacologic properties. Fed. Proc. 45:581 (1986).
K. H. Byington. Pharmacologic properties of catecholamine phosphate esters. Fed. Proc. 46:699 (1987).
N. Frank, E. Frei, and M. Wiessler. Metabolism of N-nitrosohydroxyethyl-alkylamine phosphate esters in the rat. Toxicology 57:59–67 (1989).
V. E. Bamann and P. Schwarze. Die stereochemische spezifitat der “alkalischen” phosphatase bei der spaltung phosphoman-delsaure. Ein beitrag zum mechanisms des optischen auswahlens von enzymen. Hoppe-Seyler Z. Physiol. Chem. 349:192–196 (1968).
H. Lineweaver and D. Burk. The determination of enzyme dissociation constants. J. Am. Chem. Soc. 56:658–666 (1934).
T. W. Reid and I. B. Wilson. In P. D. Boyer (ed.), The Enzymes, Vol. 4, 3rd ed., 1971, p. 373.
J. M. Sowadski, M. D. Handschumacher, H. M. Krishina Murty, B. A. Foster, and H. W. Wyckoff. Refined structure of alkaline phosphatase from Escherichia coli at 2.8A resolution. J. Mol. Biol. 186:417–433 (1985).
A. Williams and R. A. Naylor. Evidence for SN2(P) mechanism in the phosphorylation of alkaline phosphate by substrates. J. Chem. Soc. B 1973–1979 (1971).
A. J. Kirby and A. G. Varvoglis. The reactivity of phosphate esters. Monoester hydrolysis. J. Am. Chem. Soc. 89:415–423 (1967).
A. D. Hall and A. Williams. Leaving group dependence in the phosphorylation of Escherichia coli alkaline phosphatase by mono-phosphate esters. Biochemistry 25:4784–4790 (1986).
S. J. Benkovic and K. J. Schray. Metal ion catalysis of phosphoryl transfer from phosphoenolpyruvate. Biochemistry 7:4097–4102 (1968).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kearney, A.S., Stella, V.J. The in Vitro Enzymic Labilities of Chemically Distinct Phosphomonoester Prodrugs. Pharm Res 9, 497–503 (1992). https://doi.org/10.1023/A:1015840329786
Issue Date:
DOI: https://doi.org/10.1023/A:1015840329786